CStone Pharmaceuticals CSPHF 价格预测与展望

Q: 技术分析指标如何适用于 CSPHF？

根据技术分析，CStone Pharmaceuticals 的综合信号为 Buy。CStone Pharmaceuticals 有 1 个买入信号，6 个中性信号和 0 个卖出信号。

Q: CSPHF 的斐波那契回调水平是多少？

CStone Pharmaceuticals 的斐波那契回调水平是 在 78.6% 和 100% 之间。

Q: CStone Pharmaceuticals 的 RSI 是多少？

CStone Pharmaceuticals 的 RSI 目前为 62.89，表明处于 中立 状态

Q: CStone Pharmaceuticals 接下来 12 个月的价格是多少？

CStone Pharmaceuticals CSPHF 接下来 12 个月的价格预计为 $13.92。

Q: CStone Pharmaceuticals 预计会涨到多高？

据华尔街分析师称，CStone Pharmaceuticals 预计将达到 $21 的高预测值。

主页

股票

CSPHF

预测

CSPHF 股票价格预测

CStone Pharmaceuticals

$0.85

收盘价：Jan 16, 16:00:00 GMT-5

$0.85

盘后：Jan 16, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$0.858

开盘价

$0.8584

当日区间

$0.858 - $0.8584

52周范围

$0.226 - $1

交易量

310

平均成交量

每股收益（TTM）

-0.04

股息收益率

市值

$1.2B

什么是 CSPHF？

Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. The company is headquartered in Suzhou, Jiangsu and currently employs 93 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The firm is also engaged in the development and commercialization of immuno-oncology. The firm primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for CSPHF in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $13.92. The lowest target is $7.38 and the highest is $21. Empower your investment choices with our cutting-edge, data-driven analysis!

CSPHF 股价预测摘要

CSPHF的顶级分析师评级

基于 7 位分析师对 CSPHF 的股票评级，更新于 Sep 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for CSPHF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: CSPHF is a Buy candidate.

CSPHF stock price ended at $0.86 on 星期四, after rising 11.69%

On the latest trading day Jan 15, 2026, the stock price of CSPHF rose by 11.69%, climbing from $0.82 to $0.86. Throughout the session, the stock experienced a volatility of 4.88%, with prices fluctuating between a daily low of $0.82 and a high of $0.86. Alongside this price increase, trading volume also rose by 832 shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 620 shares were traded, amounting to a market value of approximately $1.2B.

CSPHF 技术面信号

技术面信号摘要

购买信号 1

中性信号 6

卖出信号 0

Strong Sell

Sell

Neutral

Buy

Strong Buy

CSPHF目前显示1个买入信号和0个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为24.64%。总体而言，技术指标显示中期前景为Buy。

CSPHF 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 CSPHF 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 CSPHF？



CSPHF 的斐波那契回调水平是多少？



CStone Pharmaceuticals 的 RSI 是多少？



CStone Pharmaceuticals 接下来 12 个月的价格是多少？



CStone Pharmaceuticals 预计会涨到多高？



CStone Pharmaceuticals（CSPHF）价格

CSPHF 股价走势图